Oct. - Nov. 2026: Introductory Course in Exploratory Medicines Development 2026 - Part I & Part II
This course addresses postgraduates in life sciences interested in early clinical development of medicinal products. Two training parts of several days provide a concise overview on Human Pharmacology / Translational Medicine spanning from non-clinical pharmacology and toxicology over first-in-man studies to proof-of-concept clinical trials.
Part I – Online
21 October – 5 November 2026
6 half-days
Part II – Face-to-Face
24–27 November 2026
Oberursel, near Frankfurt/Main
Both parts can be booked separately or in combination.
Further information and registration are available on the AGAH website:
View on AGAH Website
DOWNLOAD PRESENTATIONS: 4th EUFEMED Conference - Mastering the New Time Pressure on Human Pharmacology
4th EUFEMED Conference - Mastering the New Time Pressure on Human Pharmacology
Presentationsare now available, click the link below to reach the Presentations' Page.
Patients and the public experienced rapid availability of new vaccines and treatments against COVID-19 infections during the pandemic in 2020. Although it is obvious that this was due to exceptional circumstances, it has raised the expectations for shorter development times for future medicines. Therefore, time pressure on clinical researchers and regulators has further increased and calls for innovation and creativity. In the EUFEMED 2023 conference we will discuss options and strategies for Mastering the New Time Pressure on Human Pharmacology in order to achieve shorter timelines in early medicines development.